Vivian Tat

Also affiliated with The University of Texas Medical Branch at Galveston

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The Development of a Novel Nanobody Therapeutic for SARS-CoV-2”.

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.17.386532

N/A

0.489DataRank · unranked

25 citations

Joseph P. Gallant, Christopher Massey, Ke Shi, Wanbo Tai, Jian Zheng +14 more

Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection

Mammalian Genome(2024)10.1007/s00335-024-10033-8

N/A

0.292DataRank · unranked

6 citations

Megan Washington, Carolina Leynes, Jason Hsu, Kempaiah Rayavara, Yangjin Bae +12 more

Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents

Frontiers in Chemistry(2022)10.3389/fchem.2022.867928

N/A

0DataRank · unranked

13 citations

Linfeng Li, Aleksandra Drelich, Balachandra Chenna, Drake M. Mellott, Zane W. Taylor +6 more

Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.19.549739

N/A

0DataRank · unranked

1 citations

Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan +16 more

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Science Translational Medicine(2024)10.1126/scitranslmed.adi0979

N/A

0DataRank · unranked

43 citations

Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan +17 more

A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.28.489809

N/A

0DataRank · unranked

3 citations

Swati Jain, Jian Sha, Himanshu Batra, Neeti Ananthaswamy, Paul B. Kilgore +13 more

A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.23.347534

N/A

0DataRank · unranked

17 citations

Chien‐Te K. Tseng, Aleksandra Drelich, Pavla Fajtová, Balachandra Chenna, Demetrios H. Kostomiris +24 more